Beth Cooper

1.6k total citations
6 papers, 818 citations indexed

About

Beth Cooper is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Beth Cooper has authored 6 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Organic Chemistry and 2 papers in Oncology. Recurrent topics in Beth Cooper's work include Cancer therapeutics and mechanisms (1 paper), Bioactive Compounds and Antitumor Agents (1 paper) and Synthesis of heterocyclic compounds (1 paper). Beth Cooper is often cited by papers focused on Cancer therapeutics and mechanisms (1 paper), Bioactive Compounds and Antitumor Agents (1 paper) and Synthesis of heterocyclic compounds (1 paper). Beth Cooper collaborates with scholars based in United States. Beth Cooper's co-authors include Jonathan L. Doty, John C. Kath, Karen H. Martin, W. Gregory Roberts, Ethan Ung, Michael J. Luzzio, Robert W. Tilghman, Jill K. Slack‐Davis, J. Thomas Parsons and Christopher Autry and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Tetrahedron Letters.

In The Last Decade

Beth Cooper

6 papers receiving 803 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Beth Cooper United States	6	504	230	201	142	122	6	818
Michael J. Luzzio United States	12	709 1.4×	234 1.0×	193 1.0×	260 1.8×	204 1.7×	14	1.1k
Françoise Perron‐Sierra France	14	517 1.0×	333 1.4×	105 0.5×	156 1.1×	135 1.1×	22	925
Anthony Cormier United States	12	380 0.8×	113 0.5×	201 1.0×	120 0.8×	166 1.4×	15	642
Miljenko Mervič United States	11	863 1.7×	279 1.2×	177 0.9×	141 1.0×	241 2.0×	16	1.3k
Daniel Scheibe United States	5	455 0.9×	59 0.3×	119 0.6×	92 0.6×	167 1.4×	5	847
Michael A. Dechantsreiter Germany	10	690 1.4×	415 1.8×	59 0.3×	345 2.4×	179 1.5×	12	1.1k
Johannes Ottl Switzerland	19	731 1.5×	68 0.3×	51 0.3×	155 1.1×	192 1.6×	32	1.1k
Chris R. Evelyn United States	13	777 1.5×	69 0.3×	245 1.2×	32 0.2×	183 1.5×	14	1.0k
Paul Tapang United States	14	444 0.9×	37 0.2×	123 0.6×	143 1.0×	236 1.9×	29	773
Hirokazu Iida Japan	17	339 0.7×	177 0.8×	105 0.5×	321 2.3×	97 0.8×	57	900

Countries citing papers authored by Beth Cooper

Since Specialization

Citations

This map shows the geographic impact of Beth Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beth Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beth Cooper more than expected).

Fields of papers citing papers by Beth Cooper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beth Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beth Cooper. The network helps show where Beth Cooper may publish in the future.

Co-authorship network of co-authors of Beth Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of Beth Cooper. A scholar is included among the top collaborators of Beth Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beth Cooper. Beth Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Slack‐Davis, Jill K., Karen H. Martin, Robert W. Tilghman, et al.. (2007). Cellular Characterization of a Novel Focal Adhesion Kinase Inhibitor. Journal of Biological Chemistry. 282(20). 14845–14852. 408 indexed citations

2.

Munchhof, Michael J., Jean S. Beebe, Beth Cooper, et al.. (2003). Design and SAR of thienopyrimidine and thienopyridine inhibitors of VEGFR-2 kinase activity. Bioorganic & Medicinal Chemistry Letters. 14(1). 21–24. 86 indexed citations

3.

Ragan, John A., Jeffrey W. Raggon, Brian P. Jones, et al.. (2003). Cross-Coupling Methods for the Large-Scale Preparation of an Imidazole−Thienopyridine: Synthesis of [2-(3-Methyl-3H-imidazol-4-yl)- thieno[3,2-b]pyridin-7-yl]-(2-methyl-1H-indol-5-yl)-amine. Organic Process Research & Development. 7(5). 676–683. 43 indexed citations

4.

Sobolov, Susan B., Jianmin Sun, & Beth Cooper. (1998). Selective N-alkylation of pyrrolopyrimidines and indoles by “transfer of activation”. Tetrahedron Letters. 39(32). 5685–5688. 9 indexed citations

5.

Schnur, Rodney C., Michael L. Corman, Randall J. Gallaschun, et al.. (1995). erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationships. Journal of Medicinal Chemistry. 38(19). 3813–3820. 110 indexed citations

6.

Schnur, Rodney C., Michael L. Corman, Randall J. Gallaschun, et al.. (1995). Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivatives. Journal of Medicinal Chemistry. 38(19). 3806–3812. 162 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact